Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Rating) has been given a consensus rating of “Hold” by the nine ratings firms that are covering the firm, reports Marketbeat.com. One equity research analyst has rated the stock with a sell recommendation, four
Health Department let NYCHA cover up lead paint hazards even after child was hospitalized: lawsuit
The city’s Health Department allowed the New York City Housing Authority to cover up test results showing hazardous levels of lead paint in a residential unit and skirt responsibility to remediate the conditions, even after a child was hospitalized with

